SELLAS Life Sciences Group (SLS) Institutional Ownership $1.86 +0.10 (+5.37%) As of 11:07 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for SELLAS Life Sciences Group (NASDAQ:SLS)CurrentInstitutional OwnershipPercentage17.38%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$10.03MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$49.34K Get SLS Insider Trade Alerts Want to know when executives and insiders are buying or selling SELLAS Life Sciences Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SLS Institutional Buying and Selling by Quarter SELLAS Life Sciences Group Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2025Anson Funds Management LP7,579,095$8.19M1.3%+535.7%7.596% 5/12/2025Virtu Financial LLC53,861$58K0.0%+30.9%0.057% 2/28/2025 Brooklyn FI LLC594,919$677K0.1%N/A0.845% 2/17/2025Anson Funds Management LP1,192,266$1.24M0.1%+50.2%1.694% 2/14/2025Northern Trust Corp134,721$140K0.0%+33.6%0.191% 2/13/2025XTX Topco Ltd53,426$56K0.0%-14.9%0.076% 2/12/2025Geode Capital Management LLC733,546$763K0.0%+21.2%1.042% 2/11/2025Virtu Financial LLC41,155$43K0.0%-48.1%0.058% 2/11/2025 Brooklyn FI LLC594,919$677K0.0%N/A0.845% 1/31/2025Opus Capital Group LLC238,500$248K0.0%+5.5%0.339% Get the Latest News and Ratings for SLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE daily newsletter. 11/20/2024Virtu Financial LLC79,241$99K0.0%+24.1%0.113% 11/16/2024Geode Capital Management LLC605,191$757K0.0%+17.1%0.941% 11/15/2024Anson Funds Management LP793,835$992K0.0%N/A1.234% 11/15/2024XTX Topco Ltd62,785$78K0.0%N/A0.098% 11/15/2024State Street Corp174,529$218K0.0%+30.2%0.271% 8/9/2024Renaissance Technologies LLC32,446$39K0.0%N/A0.056% 5/20/2024Virtu Financial LLC39,429$40K0.0%-34.2%0.068% 5/14/2024Anson Funds Management LP4,832,368$4.88M0.3%N/A8.366% 4/26/2024Opus Capital Group LLC200,600$203K0.0%+48.6%0.356% 2/13/2024Armistice Capital LLC820,000$869K0.0%N/A2.558% 1/31/2024Opus Capital Group LLC135,000$143K0.0%+291.3%0.421% 9/12/2023Prosperity Financial Group Inc.29,800$47K0.0%N/A0.105% 5/11/2023Highbridge Capital Management LLC1,805,054$2.58M0.0%N/A6.367% 1/18/2023Opus Capital Group LLC19,672$46K0.0%N/A0.096% 11/15/2022Empery Asset Management LP308,466$623K3.7%-66.8%1.501% 2/14/2022GSA Capital Partners LLP10,447$58K0.0%N/A0.066% 2/11/2022Equitable Holdings Inc.102,000$564K0.0%+2.0%0.642% 11/12/2021Jump Financial LLC14,627$134K0.0%N/A0.092% 11/12/2021Equitable Holdings Inc.100,000$916K0.0%+6.0%0.630% 11/12/2021Geode Capital Management LLC133,801$1.23M0.0%+32.0%0.843% 8/25/2021Marshall Wace LLP84,544$938K0.0%+63.0%0.533% 8/17/2021Price T Rowe Associates Inc. MD15,500$172K0.0%-42.8%0.103% 8/16/2021Morgan Stanley15,499$172K0.0%+297.4%0.103% 8/16/2021Pinz Capital Management LP10,700$119K0.0%-18.3%0.071% 8/16/2021State Street Corp37,468$416K0.0%N/A0.248% 8/16/2021Marshall Wace LLP84,544$938K0.0%+63.0%0.560% 8/13/2021Northern Trust Corp24,605$273K0.0%+35.9%0.163% 8/13/2021Geode Capital Management LLC101,337$1.12M0.0%+6.8%0.672% 8/13/2021Vanguard Group Inc.618,534$6.87M0.0%+31.6%4.100% 8/12/2021Dimensional Fund Advisors LP20,320$226K0.0%+31.9%0.135% Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow8/12/2021Bank of Montreal Can109,282$1.43M0.0%N/A0.724% 8/11/2021Bank of New York Mellon Corp20,332$226K0.0%+30.3%0.135% (Data available from 1/1/2016 forward) SLS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SLS shares? During the previous two years, 11 institutional investors and hedge funds held shares of SELLAS Life Sciences Group. The most heavily invested institutionals were Anson Funds Management LP ($8.19M), Armistice Capital LLC ($869K), Geode Capital Management LLC ($763K), Brooklyn FI LLC ($677K), Opus Capital Group LLC ($248K), State Street Corp ($218K), and Northern Trust Corp ($140K).Learn more on SELLAS Life Sciences Group's institutional investors. What percentage of SELLAS Life Sciences Group's stock is owned by institutional investors? 17.38% of SELLAS Life Sciences Group's stock is owned by institutional investors. Learn more on SLS's institutional investor holdings. Which institutional investors have been buying SELLAS Life Sciences Group's stock? Of the 11 institutional investors that purchased SELLAS Life Sciences Group's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Anson Funds Management LP ($12.41M), Brooklyn FI LLC ($1.19M), Armistice Capital LLC ($820K), Geode Capital Management LLC ($216.54K), Opus Capital Group LLC ($178.50K), XTX Topco Ltd ($62.79K), and State Street Corp ($40.50K). How much institutional buying is happening at SELLAS Life Sciences Group? Institutional investors have bought a total of 9,195,584 shares in the last 24 months. This purchase volume represents approximately $10.03M in transactions. Which of SELLAS Life Sciences Group's major shareholders have been selling company stock? The following institutional investors have sold SELLAS Life Sciences Group stock in the last 24 months: Virtu Financial LLC ($38.09K), and XTX Topco Ltd ($9.36K). How much institutional selling is happening at SELLAS Life Sciences Group? Institutional investors have sold a total of 47,445 shares in the last 24 months. This volume of shares sold represents approximately $49.34K in transactions. Related Companies CorMedix Major Shareholders Vir Biotechnology Major Shareholders KalVista Pharmaceuticals Major Shareholders Amylyx Pharmaceuticals Major Shareholders ArriVent BioPharma Major Shareholders Immatics Major Shareholders Immunome Major Shareholders Nuvation Bio Major Shareholders MeiraGTx Major Shareholders Gyre Therapeutics Major Shareholders This page (NASDAQ:SLS) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SELLAS Life Sciences Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SELLAS Life Sciences Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.